Coverage
-
June 05, 2013
A New Jersey federal judge said Tuesday that Braintree Laboratories Inc.'s patent on Suprep is valid, a ruling that follows the judge's finding in January that Novel Laboratories Inc.'s plan to make a generic version of the colon cleanser infringed the patent.
1 other articles on this case.
View all »